Ruxolitinib versus best available therapy for PV intolerant or resistant to Hydroxycarbamide a randomised trial
Loading...
Embargo End Date
ICR Authors
Authors
Harrison, C
Nangalia, J
Boucher, R
Jackson, A
Yap, C
O'Sullivan, J
Fox, S
Ailts, I
Dueck, A
Geyer, H
Mesa, R
Dunn, W
Nadezhdin, E
Curto-Garcia, N
Green, A
Wilkins, B
Coppell, J
Laurie, J
Garg, M
Ewing, J
Knapper, S
Crowe, J
Chen, F
Koutsavlis, I
Godfrey, A
Arami, S
Drummond, M
Byrne, J
Clark, F
Mead-Harvey, C
Baxter, E
McMullin, MF
Mead, A
Nangalia, J
Boucher, R
Jackson, A
Yap, C
O'Sullivan, J
Fox, S
Ailts, I
Dueck, A
Geyer, H
Mesa, R
Dunn, W
Nadezhdin, E
Curto-Garcia, N
Green, A
Wilkins, B
Coppell, J
Laurie, J
Garg, M
Ewing, J
Knapper, S
Crowe, J
Chen, F
Koutsavlis, I
Godfrey, A
Arami, S
Drummond, M
Byrne, J
Clark, F
Mead-Harvey, C
Baxter, E
McMullin, MF
Mead, A
Document Type
Conference Proceeding
Date
2023-04-01
Date Accepted
2023-03-21
Abstract
Citation
British Journal of Haematology, 2023, 201 pp. 88 - 88
DOI
Source Title
British Journal of Haematology
Publisher
WILEY
ISSN
0007-1048
eISSN
1365-2141
1365-2141
1365-2141
Collections
Research Team
Clin Trials & Stats Unit